Audrey Duval

Head of Corporate Affairs and President of Sanofi France · Sanofi

Pharmaceuticals

Audrey Duval is Sanofi’s head of Corporate Affairs and president of Sanofi France, following medical practice, research and pharmaceutical commercial leadership.

Last reviewed: Nov 15, 2026

Audrey Duval

Executive Summary

Audrey Duval is Sanofi’s head of Corporate Affairs and president of Sanofi France, following medical practice, research and pharmaceutical commercial leadership.

Career Highlights

  • Began in public hospitals in Paris and research in Hong Kong.
  • Led Novartis’s ophthalmology franchise and Irish business.
  • Joined Sanofi as president of its French operations in September 2022.

Professional Journey

Duval began her career in public hospitals in Paris. She subsequently worked as a researcher at the Pasteur Research Center of Hong Kong University and as a scientific expert at Hong Kong-based Salusmed.

After returning to France, she joined Pfizer and worked in medical affairs across endocrinology, transplantation and rheumatology. She later moved to Novartis, serving as business franchise head for Ophthalmology and then country president for its Irish operations.

Duval joined Sanofi in September 2022 as president of Sanofi France. Her work includes coordinating the company’s representation with external stakeholders in France, alongside its broader corporate-affairs responsibilities.

Sanofi’s leadership structure effective September 1, 2026 retains Duval as head of Corporate Affairs and president of Sanofi France, reporting directly to the chief executive. Her career combines clinical medicine and research with medical affairs, therapeutic-franchise management, national business leadership and stakeholder engagement.

Education

Duval holds a medical doctorate from the Paris Faculty of Medicine Cochin. Her issuer biography also records a BSc in medical biology without naming its awarding institution.